a16z Podcast

It's easier to move upmarket than down. We look at why this gives SaaS startups the advantage against incumbents and how to price for the move.

Today’s episode is about a practical application of crypto — namely, the way it can “tokenize” fandom. More broadly, it’s about fan engagement, and the increasingly blurred lines between sports, culture and tech.  We talked to NBA player Spencer Dinwiddie, of the Brooklyn Nets. Spencer created a new platform on the crypto blockchain Ethereum that gives fans the opportunity to invest directly in his revenue-generating potential, through debt securities...

with @PascaStanford, @VijayPande, and @omnivorousread Our understanding of the human brain and its disorders has always been limited by our lack of access to living, human, developing brain tissue. For the first time, that's changing. In this episode, Sergiu Pasca, Professor of Behavioral Science at Stanford, talks with a16'z General Partner Vijay Pande and Hanne Tidnam about the wild new tech that's pioneering a whole new approach to understanding the brain: brain organoids...

with @nachristakis @jorgecondebio Going from rapid warning to early detection through social network sensors can make all the difference when it comes to contagion/ the spread of disease and pandemics. Can we get public health bio surveillance without sacrificing privacy and agency?

with @nwquah @conniechan and @smc90 This (rerun) podcast is a podcast about podcasting: But it's really all about audio...

In normal times, every company operates against some hypothetical growth model—a data-driven framework that describes how your product grows and how you acquire new users. These, of course, are not normal times. In the fallout from the pandemic, most founders and CEOs are in the process of completely revamping their growth models from the bottom up amid new and unpredictable consumer behavior...

with @vijaypande, @andy23tran, and @lr_bio a16z Journal Club covers a new approach for preventing coronavirus and influenza infection using the genome editing platform CRISPR-Cas.

John Riccitiello, CEO of the game software development company Unity Technologies, discusses the rise of esports and streaming, the potential of cloud gaming, and far-reaching applications for game technology.

with @jaybrander, @JorgeCondeBio, @omnivorousread A deep dive into the world of drug development—specifically "undruggable drugs": a category of protein, protein family or even piece of RNA that’s so difficult to target that many researchers don’t even want to touch it—with Jay Bradner, President of the Novartis Institute for BioMedical Research.

This episode—which originally took place as a live event—is a conversation between Seattle Seahawks linebacker Bobby Wagner and a16z Cultural Leadership Fund partner Chris Lyons.